Bank of Maharashtra Other Announcement

Bank of Maharashtra Earnings Call Transcript: Key Takeaways

Bank of Maharashtra delivers a robust quarter with 25% business growth, record ROA of 2.02%, and best-in-class asset quality. Management successfully defended margins through strategic re-pricing and low-cost funding.

Call

Guides 18% growth

Bank of Maharashtra Results Update

Bank of Maharashtra reported Q2 FY27 net profit of ₹2,310 crore, up 41.42% YoY. Total business grew 25.16% to ₹7,05,766 crore.

Bank of Maharashtra Investor Presentation: Key Takeaways

Q2 FY27 net profit ₹2,310 Cr (+41.42% YoY); operating profit ₹3,369 Cr (+30.86%); global advances +29.61%; GNPA 1.25%.

Bank of Maharashtra Q2 FY27 Results: Net Profit ₹2,136 Cr, Up 28.0% YoY

Bank of Maharashtra reported revenue from operations of ₹8,606 Cr (+20.7% YoY) and net profit of ₹2,136 Cr (+28.0% YoY) for Q2 FY27.

Key figure

Net profit ₹2,136 Cr · +28.0% YoY

Bank of Maharashtra Board Meeting Date

Bank of Maharashtra will hold a board meeting on 26th October 2026 to approve financial results for the quarter and half-year ended 30th September 2026.

Bank of Maharashtra Debt & Borrowing: ₹78.6 Cr

Bank of Maharashtra paid Rs. 78.60 crore annual interest on Basel III Tier II Bonds (INE457A08092). Payment made on 21 October 2026 per Reg 57(1).

Value

₹78.60 Cr

Mahindra & Mahindra Financial Services Other Announcement

Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.

ACME Solar Holdings Other Announcement

ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.

eMudhra Other Announcement

eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.

Aarti Pharmalabs Other Announcement

Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.

Sagarsoft (India) Other Announcement

Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.

Sadhana Nitro Chem Other Announcement

Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.